Rapport Therapeutics, Inc. Common Stock (RAPP)

10.27

(0.88%)

Operating Expenses Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual operating expenses in 2023 was 36.06 Million USD , up 248.41% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly operating expenses in 2024 Q2 was 20.59 Million USD , up 21.54% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a annual operating expenses of 10.35 Million USD in annual operating expenses 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly operating expenses of 16.94 Million USD for 2024 Q1, up 14.52% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly operating expenses of 36.06 Million USD for 2023 FY, up 248.41% from previous quarter.

Annual Operating Expenses Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Operating Expenses of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Operating Expenses Operating Expenses Growth
2023 36.06 Million USD 248.41%
2022 10.35 Million USD 0.0%

Peer Operating Expenses Comparison of Rapport Therapeutics, Inc. Common Stock

Name Operating Expenses Operating Expenses Difference